
Bold Capital Partners
Description
Bold Capital Partners, based in Santa Monica, California, is a venture capital firm co-founded by XPRIZE founder Peter Diamandis and entrepreneur Robert Herjavec. The firm specializes in early-stage investments, primarily targeting Series A and Series B rounds, with a strategic focus on "exponential technologies" and "frontier tech." They aim to back companies that are leveraging disruptive innovations to transform industries.
Their investment thesis centers on companies utilizing advancements in areas such as artificial intelligence, robotics, biotechnology, space exploration, and advanced materials. Bold Capital seeks out ventures with the potential to create significant market shifts, achieve "10x improvements," or address "billion-dollar markets." The firm has successfully raised multiple funds, with their latest, Fund III, closing at a substantial $250 million. This capital base enables them to make meaningful initial investments and provide ongoing support to their portfolio companies through subsequent funding rounds.
While specific check sizes can vary depending on the opportunity and stage, Bold Capital typically deploys initial investments ranging from approximately $3 million to $15 million, often co-investing alongside other prominent venture firms. Their value proposition extends beyond capital, offering portfolio companies access to a robust network of strategic partners, industry experts, and the unique insights of their founders, particularly in areas related to innovation and exponential growth. Bold Capital Partners positions itself as a long-term partner for visionary entrepreneurs building the next generation of transformative companies.
Investor Profile
Bold Capital Partners has backed more than 106 startups, with 8 new investments in the last 12 months alone. The firm has led 23 rounds, about 22% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Seed rounds (top funding stages).
- Majority of deals are located in United States, Hong Kong, Canada.
- Strong thematic focus on Health Care, Biotechnology, Artificial Intelligence (AI).
- Led 4 rounds in the past year.
- Typical check size: $3M – $15M.
Stage Focus
- Series A (35%)
- Series B (23%)
- Seed (20%)
- Series Unknown (10%)
- Series C (5%)
- Series D (3%)
- Pre Seed (2%)
- Convertible Note (1%)
- Series F (1%)
- Series E (1%)
Country Focus
- United States (91%)
- Hong Kong (6%)
- Canada (2%)
- Finland (1%)
- Israel (1%)
Industry Focus
- Health Care
- Biotechnology
- Artificial Intelligence (Ai)
- Software
- Medical
- Medical Device
- Therapeutics
- Machine Learning
- Robotics
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.